Search result for BIOSIMILARS
CELLTRION’S YEAR-END PROFIT, BIOSIMILARS DEMAND AT THE OVERSEAS MARKET
Highlights –
- Pharmaceutical giant Celltrion makes operating profit
- Biosimilars in demand
- Company aims to add 46 more new drugs by 2022
South Korean pharmaceutical giant and leading drug maker Celltrion Inc. ha...
THREE NEW ONCOLOGY BIOSIMILARS INTRODUCED IN US MARKETS
Highlights:
- Bevacizumab-bvzr, rituximab-pvvr, and Trastuzumab-qyyp have been introduced in the United States.
- Pfizer will become the first manufacturer to launch 3 oncology biosimilar products in the US market.
- The 3 antibodies will be avai...